share_log

Purple Biotech Reports Q3 Basic And Diluted Loss Per ADS Of $0.39, Exits Quarter With Cash & Equivalents Worth $5.438M

Purple Biotech Reports Q3 Basic And Diluted Loss Per ADS Of $0.39, Exits Quarter With Cash & Equivalents Worth $5.438M

purple biotech發佈第三季度每ADS基本和稀釋虧損爲$0.39,季度末現金及等價物價值$5.438M
Benzinga ·  11/15 20:08

Purple Biotech Reports Q3 Basic And Diluted Loss Per ADS Of $0.39, Exits Quarter With Cash & Equivalents Worth $5.438M

purple biotech發佈第三季度每ADS基本和稀釋虧損爲$0.39,季度末現金及等價物價值$5.438M

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論